Literature DB >> 16026320

Oxidative-nitrosative stress in hypertension.

Nelson Escobales1, Maria J Crespo.   

Abstract

Reactive oxygen species (ROS) are important signaling molecules in the vasculature. However, when there is imbalance between their occurrence and antioxidant defense mechanisms, ROS can contribute to the vascular abnormalities that lead to hypertension. Evidence accumulated in the last decade strongly supports the notion that ROS are generated in the vasculature mainly by NAD(P)H oxidase in a mechanism that is angiotensin II-dependent. Activation of this enzyme leads to superoxide production and uncouples endothedial NO synthase (eNOS), which sustains oxidative stress while increasing the levels of tissue-damaging peroxynitrite. The latter can result in vascular dysfunction. NAD(P)H-dependent ROS formation, in particular H(2)O(2), could also contribute to vascular injury by sustaining NAD(P)H oxidase activation, promoting inflammatory gene expression, extracellular matrix reorganization, and growth (hypertrophy/hyperplasia) of vascular smooth muscle cells. The effect of ROS appears to be mediated by redox-sensitive targets such as tyrosine kinases and phosphatases, mitogen-activated protein kinases, transcription factors, matrix metalloproteinases, peroxisome proliferator activated receptor-alpha, poly(ADP-ribose)polymerase-1, Ca(2+) signaling mechanisms and secreted factors such as cyclophilin A and heat shock protein 90-alpha. Redox-sensitive targets appear to play a central role in normal vascular function, but can also lead to remodeling of the vascular wall, increasing vascular reactivity and hypertension. Polymorphisms in the p22phox gene promoter could determine susceptibility to NAD(P)H-mediated oxidative stress in humans and animals with hypertension. Although ROS are strongly implicated in the etiology of hypertension, clinical trials with antioxidants are inconclusive regarding their effectiveness in treating the disease. New drugs with both antihypertensive action and antioxidant properties (Celiprolol, Carvedilol) offer promising results in the management of hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026320     DOI: 10.2174/1570161054368643

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  23 in total

1.  Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma.

Authors:  I Tasset; C Espínola; F J Medina; M Feijóo; C Ruiz; E Moreno; M M Gómez; J A Collado; C Muñoz; J Muntané; P Montilla; I Túnez
Journal:  J Physiol Biochem       Date:  2009-09       Impact factor: 4.158

2.  Reactive nitrogen species reactivities with nitrones: theoretical and experimental studies.

Authors:  Kevin M Nash; Antal Rockenbauer; Frederick A Villamena
Journal:  Chem Res Toxicol       Date:  2012-07-31       Impact factor: 3.739

3.  The characteristics of motor activity in ISIAH rats in an open field test are controlled by genes on chromosomes 2 and 16.

Authors:  O E Redina; S E Smolenskaya; L N Maslova; D G Sakharov; A L Markel'
Journal:  Neurosci Behav Physiol       Date:  2008-12-17

Review 4.  Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease.

Authors:  Pravin Kesarwani; Anuradha K Murali; Amir A Al-Khami; Shikhar Mehrotra
Journal:  Antioxid Redox Signal       Date:  2012-10-15       Impact factor: 8.401

Review 5.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 6.  The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease.

Authors:  Simon W Rabkin
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

7.  Exercise training, NADPH oxidase p22phox gene polymorphisms, and hypertension.

Authors:  Deborah L Feairheller; Michael D Brown; Joon-Young Park; Tina E Brinkley; Samar Basu; James M Hagberg; Robert E Ferrell; Nicola M Fenty-Stewart
Journal:  Med Sci Sports Exerc       Date:  2009-07       Impact factor: 5.411

Review 8.  Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.

Authors:  Pal Pacher; Csaba Szabo
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

Review 9.  Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.

Authors:  Pál Pacher; Csaba Szabó
Journal:  Cardiovasc Drug Rev       Date:  2007

10.  Association of NADPH oxidase p22phox gene C242T, A640G and -930A/G polymorphisms with primary knee osteoarthritis in the Greek population.

Authors:  Panagiotis Lepetsos; Andreas Pampanos; Stergios Lallos; Emmanouil Kanavakis; Dimitrios Korres; Athanasios G Papavassiliou; Nicolaos Efstathopoulos
Journal:  Mol Biol Rep       Date:  2013-08-07       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.